Treatment of chronic myeloid leukemia with imatinib: IRIS study

被引：0
|
作者：
Saußele S. [1 ]
Nitschmann S. [2 ]
机构：
[1] III. Medizinische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, Mannheim
来源：
Der Internist | 2017年 / 58卷 / 11期
关键词：
D O I：
10.1007/s00108-017-0322-0
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1220 / 1221
页数：1
相关论文
共 50 条
  • [31] Hypopigmented macules secondary to imatinib for the treatment of chronic myeloid leukemia: a histopathologic and immunohistochemical study
    Llamas-Velasco, Mar
    Fraga, Javier
    Kutzner, Heinz
    Luis Steegmann, Juan
    Garcia-Diez, Amaro
    Requena, Luis
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (05) : 417 - 426
  • [32] Imatinib - New molecular treatment for chronic myeloid leukemia. The IRIS study [Imatinib - Neuartige, molekulare therapiemöglichkeit bei chronischer myeloischer leukämie. Die IRIS-studie]
    Berger U.
    Hehlmann R.
    Der Internist, 2004, 45 (1): : 102 - 103
  • [33] Cytogenetic studies on a chronic myeloid leukemia case developing into acute myeloid leukemia after treatment with imatinib
    Kroes, Wilma
    den Ouden, Elke
    Kok, Edwin
    Kerkhoffs, Jean Louis
    CHROMOSOME RESEARCH, 2013, 21 : S85 - S85
  • [34] Imatinib sets new treatment standard in patients with chronic myeloid leukemia
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 935 - 936
  • [35] Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib
    Geelani, Sajad A.
    Rathod, Santosh G.
    Dhar, Amrit
    Atri, Pallavi
    Bhat, Javid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [36] Successful Pregnancy in a Patient with Chronic Myeloid Leukemia under Treatment with Imatinib
    Tsuzuki, Motohiro
    Inaguma, Youko
    Handa, Kousuke
    Hasegawa, Akio
    Yamamoto, Yukiya
    Watanabe, Masato
    Mizuta, Syuichi
    Maruyama, Fumio
    Okamoto, Masataka
    Emi, Nobuhiko
    INTERNAL MEDICINE, 2009, 48 (16) : 1433 - 1435
  • [37] Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Larson, Richard A.
    Guilhot, Francois
    Radich, Jerald P.
    Branford, Susan
    Hughes, Timothy P.
    Baccarani, Michele
    Deininger, Michael W.
    Cervantes, Francisco
    Fujihara, Satoko
    Ortmann, Christine-Elke
    Menssen, Hans D.
    Kantarjian, Hagop
    O'Brien, Stephen G.
    Druker, Brian J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 917 - 927
  • [38] Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate
    Lakshmaiah, K. C.
    Bhise, Rohan
    Purohit, Samit
    Abraham, Linu J.
    Lokanatha, D.
    Suresh, T. M.
    Appaji, L.
    Arunakumari, B. S.
    Govindbabu, K.
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2430 - 2433
  • [39] The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
    Eskazan, Ahmet Emre
    Elverdi, Tugrul
    Yalniz, Fevzi Firat
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Aydin, Seniz Ongoren
    Baslar, Zafer
    Aydin, Yildiz
    Tuzuner, Nukhet
    Ozbek, Ugur
    Soysal, Teoman
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2935 - 2937
  • [40] CHRONIC MYELOID LEUKEMIA TREATMENT IN BLASTIC PHASE WITH IMATINIB 600 MG
    Ionita, H.
    Ionita, I.
    Pacurar, R.
    Cheveresan, L.
    Ionita, C. O.
    Cheveresan, M.
    Nicola, D. E.
    Ionita, M.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 544 - 544
12345